Document is current
Any future updates will be listed below
-
Authors
Freedland, Stephen J. http://orcid.org/0000-0002-8104-6419
Samjoo, Imtiaz A.
Rosta, Emily
Lansing, Austin
Worthington, Evelyn
Niyazov, Alexander
Nazari, Jonathan http://orcid.org/0000-0002-4758-7588
Arondekar, Bhakti
-
Funding
Funding for this research was provided by:
Pfizer (N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A)
- License Information
-
More Information
Article History
Received: 24 May 2023
Revised: 25 July 2023
Accepted: 1 August 2023
First Online: 17 August 2023
Competing interests
: AN and BA are employees of Pfizer and own Pfizer stock. JN is supported by the 2021-2023 University of Illinois at Chicago-Pfizer Fellowship. SF is a consultant for Pfizer, Astellas, Janssen, Bayer, Merck, Astra Zeneca, Myovant, and Sanofi and a speaker for Astra Zeneca and Sanofi. IAS, EW, AL, and ER are employees of EVERSANA, Canada, which was a paid consultant to Pfizer in connection with the development of this manuscript.
